REFERENCES:

[1] Demidova-Rice, T.N., Durham, J.T. and Herman, I.M. Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing. Advanced Wound Care, 2012, 1(1), 17–22. DOI: 10.1089/wound.2011.0308.
[2] Rosique, R.G., Rosique, M.J. and Farina Junior, J.A. Curbing inflammation in skin wound healing: A review. International Journal of Inflammation, 2015, Article ID 316235. DOI: 10.1155/2015/316235.
[3] Davis, F.M., Kimball, A., Boniakowski, A. and Gallagher, K. Dysfunctional wound healing in diabetic foot ulcers: New crossroads. Current Diabetes Reports, 2018, 18(10), 2. DOI: 10.1007/s11892-018-0970-z.
[4] patel, S., Srivastava, S., Singh, M.R. and Singh, D. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomedicine & Pharmacotherapy, 2019, 112, 108615. DOI: 10.1016/j.biopha.2019.108615.
[5] Rogers, H.D., Desciak, E.B., Marcus, R.P., Wang, S., MacKay-Wiggan, J. and Eliezri, Y.D. Prospective study of wound infections in Mohs micrographic surgery using clean surgical technique in the absence of prophylactic antibiotics. Journal of the American Academy of Dermatology, 2010, 63(5), 842–845.
[6] Martin, E.T., Kaye, K.S. and Knott, C. Diabetes and risk of surgical site infection: A systematic review and meta-analysis. Infection Control & Hospital Epidemiology, 2016, 37(10), 88–99. DOI: 10.1017/ice.2015.249.
[7] Pourmoussa, A., Gardner, D.J., Johnson, M.B. and Wong, A.K. An update and review of cell-based wound dressings and their integration into clinical practice. Annals of Translational Medicine, 2016, 4(23), 457. DOI: 10.21037/atm.2016.12.44.
[8] Spampinato, S.F., Caruso, G.I., De Pasquale, R., Sortino, M.A. and Merlo, S. The treatment of impaired wound healing in diabetes: Looking among old drugs. Pharmaceuticals, 2020, 13(4), 60. DOI: 10.3390/ph13040060.
[9] Berlanga-Acosta, J., Schultz, G.S., López-Mola, E., Guillen-Nieto, G., García-Siverio, M. and Herrera-Martínez, L. Glucose toxic effects on granulation tissue productive cells: The diabetics’ impaired healing. BioMed Research International, 2013, Article ID 256043. DOI: 10.1155/2013/256043.
[10] Boniakowski, A.E., Kimball, A.S., Jacobs, B.N., Kunkel, S.L. and Gallagher, K.A. Macrophage-mediated inflammation in normal and diabetic wound healing. Journal of Immunology, 2017, 199(10), 17–24. DOI: 10.4049/jimmunol.1700223.
[11] Mirza, R.E., Fang, M.M., Weinheimer-Haus, E.M., Ennis, W.J. and Koh, T.J. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes, 2014, 63(3), 1031–1041. DOI: 10.2337/db13-0927.
[12] Van Putte, L., De Schrijver, S. and Moortgat, P. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: A systematic review. Scars, Burns & Healing, 2016, 2, 205951316676828. DOI: 10.1177/205951316676828.
[13] Niu, Y., Cao, X. and Song, F. Reduced dermis thickness and AGE accumulation in diabetic abdominal skin. International Journal of Lower Extremity Wounds, 2021, 20(3), 224–230. DOI: 10.1177/1534734620947570.
[14] Dronge, A.S., Perkal, M.F., Kancir, S., Concato, J., Aslan, M. and Rosenthal, R.A. Long-term glycemic control and postoperative infectious complications. Archives of Surgery, 2006, 141, 375–380.
[15] Kantar, R.S., Rifkin, W.J. and Wilson, S.C. Abdominal panniculectomy: Determining the impact of diabetes on complications and risk factors for adverse events. Plastic and Reconstructive Surgery, 2018, 142(4), 462e–471e. DOI: 10.1097/PRS.0000000000004732.
[16] Akhtar, S., Barash, P.G. and Inzucchi, S.E. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesthesia & Analgesia, 2010, 110(2), 478–497. DOI: 10.1213/ANE.0b013e3181c6be63.
[17] Dortch, J.D., Eck, D.L., Ladlie, B. and TerKonda, S.P. Perioperative glycemic control in plastic surgery: Review and discussion of an institutional protocol. Aesthetic Surgery Journal, 2016, 36(7), 821–830. DOI: 10.1093/asj/sjw064.
[18] Long, M., Cai, L. and Li, W. DPP-4 inhibitors improve diabetic wound healing via direct and indirect promotion of epithelial-mesenchymal transition and reduction of scarring. Diabetes, 2018, 67(3), 518–533. DOI: 10.2337/db17-0934.
[19] Baltzis, D., Eleftheriadou, I. and Veves, A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: New insights. Advances in Therapy, 2014, 31(8), 817–836. DOI: 10.1007/s1232
[20] Barriga HMG, Holme MN, Stevens MM. Cubosomes: The next generation of smart lipid nanoparticles? Angew Chem Int Ed. 2019;58(10):2958–2978. doi:10.1002/anie.201804067.
[21] Karami, Z. and Hamidi, M. Cubosomes: Remarkable drug delivery potential. Drug Discovery Today, 2016, 21(5), 789–801. DOI: 10.1016/j.drudis.2016.01.004.
[22] Gowda BHJ, Mohanto S, Singh A, Bhunia A, Abdelgawad MA, Ghosh S, et al. Nanoparticle-based therapeutic approaches for wound healing: a review of the state-of-the-art. Materials Today Chemistry. 2023;27:101319. doi:10.1016/j.mtchem.2022.101319.
[23] Motsoene F, Abrahamse H, Dhilip Kumar SS. Multifunctional lipid-based nanoparticles for wound healing and antibacterial applications: A review. Advances in Colloid and Interface Science. 2023;321:103002. doi:10.1016/j.cis.2023.103002
[24] Pormohammad A, Monych NK, Ghosh S, Turner DL, Turner RJ. Nanomaterials in wound healing and infection control. Antibiotics. 2021;10(5):473. doi:10.3390/antibiotics10050473.
[25] Sheikh-Oleslami S, Tao B, D’Souza J, Butt F, Suntharalingam H, Rempel L, et al. A review of metal nanoparticles embedded in hydrogel scaffolds for wound healing in vivo. Gels. 2023;9(7):591
[26] Mishra A., Pandey R., Sharma S., et al. Nanotechnology-based approaches for wound healing: A review. Journal of Drug Delivery Science and Technology. 2020;55:101468.
[27] Spicer P.T., Hayden K.L., Lynch M.L., Ofori-Boateng A., Burns J.L. A fast, efficient and low-cost method for the preparation of concentrated cubic phase particles (cubosomes). Langmuir. 2001;17(19):5748–5756.
[28] Kaur S.D., Singh G., Singhal K. Cubosomes as potential nanocarrier for drug delivery: A comprehensive review. Journal of Pharmaceutical Research International. 2021;33(31B):1–15
[29] Sivadasan D., Sultan M.H., Alqahtani S.S., Javed S. Cubosomes in drug delivery—A comprehensive review on its structural components, preparation techniques and therapeutic applications. Biomedicines. 2023;11(4):1114.
[30] Gaballa S.A., El Garhy O.H., Abdelkader H. Cubosomes: composition, preparation, and drug delivery applications. Journal of Advanced Biomedical and Pharmaceutical Sciences. 2019;3(1):1–9.
[31] Zhai J, Fong C, Tran N, Drummond CJ. Cubosomes; the next generation of smart lipid nanoparticles? ACS Nano. 2019.
[32] Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic design of experiments. Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005;22(1):27-105. doi:10.1615/CritRevTherDrugCarrierSyst.v22.i1.20.
[33] Yuan N, Shao K, Huang S, Chen C. Chitosan, alginate, hyaluronic acid and other novel multifunctional hydrogel dressings for wound healing: A review. International Journal of Biological Macromolecules. 2023;240:124321.
[34] Spicer PT. Cubosome Processing Industrial Nanostructured Particles. Powder Technology. 2005;153(1):26–34.
[35] Yaghmur A, Mu H. Cubosomes: The Next Generation of Smart Lipid Nanoparticles? Acta Pharmaceutica Sinica B. 2018;8(6):892–904.
[36] Hayden KL, Lynch ML, Ofori-Boateng A, Burns JL. Novel Process for Producing Cubic Liquid Crystalline Nanoparticles (Cubosomes). Langmuir. 2001;17(19):5748–5756.
[37] Mariani P, et al. Monoolein Liquid Crystalline Dispersions as Topical Delivery Systems. Colloids and Surfaces B: Biointerfaces. 2018;171:67–74.
[38] Chong JY, Mulet X, Waddington LJ, Boyd BJ, Drummond CJ. Steric Stabilisation of Self-Assembled Cubic Lyotropic Liquid Crystal Nanoparticles. Soft Matter. 2011;7(10):4768–4777.
[39] Nasr M, Abdel-Hamid S. Lipid-based cubosomal nanoparticles for transdermal delivery of granisetron hydrochloride: optimization, formulation and in vivo evaluation. Drug Delivery. 2016;23(6):1951–1962.
[40] Rizwan SB, Dong YD, Boyd BJ, Rades T, Hook S. Characterisation of Bicontinuous Cubic Liquid Crystalline Systems of Phytantriol and Water. Journal of Pharmaceutical Sciences. 2007;96(5):1268–1276.
[41] Barauskas J., Johnsson M., Tiberg F. Self-assembled lipid superstructures: Beyond vesicles and liposomes. Nano Lett. 2005;5:1615–1619. doi: 10.1021/nl050678i
[42] Janakiraman K., Krishnaswami V., Sethuraman V., Rajendran V., Kandasamy R. Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis. Appl. Nanosci. 2019;9:1781–1796. doi: 10.1007/s13204-019-00976-9
[43] Luzzati V., Tardieu A., Gulik-Krzywicki T., Rivas E., Reiss-Husson F. Structure of the cubic phases of lipid–water systems. Nature. 1968;220:485–488. doi: 10.1038/220485a0.
[44] Melo S, et al. (for review discussions) Top-down preparation of cubosomes involves dispersing bulk cubic phases into nanoparticles using high-pressure homogenization.
[45] Assmus D, Boehnke A, Hanley T, Boyd BJ, Rades T, Hook S. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. European Journal of Pharmaceutics and Biopharmaceutics. 2011;79(1):15–22. doi:10.1016/j.ejpb.2010.12.034. This work discusses cubosome preparation and characterization and is frequently cited for sonication-based cubosome production.
[46] Abdelazem A. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole. Drug Delivery. 2015;22(1):55–63.
[47] Hafez I.M., Ansell S., Cullis P.R. Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys. J. 2000;79:1438–1446. doi: 10.1016/S0006-3495(00)76395-8.
[48] Angelov B., Angelova A., Drechsler M., Garamus V.M., Mutafchieva R., Lesieur S. Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging. Soft Matter. 2015;11:3686–3692. doi: 10.1039/C5SM00169B
[49] Esposito E, Cortesi R, Drechsler M, et al. Cubosome Dispersions as Delivery Systems for Percutaneous Administration of Drugs. Journal of Pharmaceutical Sciences. 2003;92(11):2282–2294
[50] Muir B.W., Zhen G., Gunatillake P., Hartley P.G. Salt induced lamellar to bicontinuous cubic phase transitions in cationic nanoparticles. J. Phys. Chem. B. 2012;116:3551–3556. doi: 10.1021/jp300239g.
[51] Boyd B.J., Rizwan S.B., Dong Y.-D., Hook S., Rades T. Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: Hexosomes are not necessarily flat hexagonal prisms. Langmuir. 2007;23:12461–12464. doi: 10.1021/la7029714.
[52] Rizwan SB, Boyd BJ, Rades T, Hook S. Cubosomes: Structure, Preparation and Use as an Antigen Delivery System. Expert Opinion on Drug Delivery. 2011;8(3):317–329. doi:10.1517/17425247.2011.553217.
[53] Caltagirone C., Falchi A.M., Lampis S., Lippolis V., Meli V., Monduzzi M., Prodi L., Schmidt J., Sgarzi M., Talmon Y., et al. Cancer-cell-targeted theranostic cubosomes. Langmuir. 2014;30:6228–6236. doi: 10.1021/la501332u.
[54] Murgia S., Bonacchi S., Falchi A.M., Lampis S., Lippolis V., Meli V., Monduzzi M., Prodi L., Schmidt J., Talmon Y., et al. Drug-loaded fluorescent cubosomes: Versatile nanoparticles for potential theranostic applications. Langmuir. 2013;29:6673–6679. doi: 10.1021/la401047a.
[55] Guo Q., Jiang C. Delivery strategies for macromolecular drugs in cancer therapy. Acta Pharm. Sin. B. 2020;10:979–986. doi: 10.1016/j.apsb.2020.01.009.
[56] Nasr M, Ghorab MK, Abdelazem A. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole. Drug Delivery. 2015;22(1):55–63. doi:10.3109/10717544.2013.837058
[57] Garg A, Aggarwal D, Garg S, Singla AK. Spreading of semisolid formulations: An update. Pharmaceutical Technology North America. 2002;26(9):84–105.
[58] Matthews KH, Stevens HNE, Eccleston GM. Wound healing dressings and drug delivery systems: A review. J Pharm Sci. 2008;97(8):2892–2923.
[59] Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromolecular Bioscience. 2011;11(6):748–764. doi:10.1002/mabi.201000388.